Moog price target raised to $47 from $40 at Stifel Nicolaus After Moog reported lower than expected Q1 EPS, Stifel Nicolaus expects Moog to rebound in the second half of FY13. The firm is cautious about the stock in light of sequestration risks and maintains a Neutral rating on the shares.
Dako announces collaboration agreement with Amgen Dako, an Agilent Technologies (A) company, announced a new Master Collaboration Agreement with Amgen (AMGN). The expanded collaboration will allow both companies to benefit from knowledge-sharing within the field of drug-diagnostic research and development in general, and in relation to companion diagnostic products in particular. The financial details of the agreement were not disclosed.